ArticleFrontiers in aging neuroscience2026

Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217-based assessment of CSF amyloid positivity in secondary-care patients with MCI.

María Pascual-Lucas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.